This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Passarelli, A. L. Articles by Moss, B. Search for Related Content PubMed PubMed Citation Articles by Passarelli, A. L. Articles by Moss, B.

 Previous Article  |  Next Article 

J. Virol., 07 1996, 4444-4450, Vol 70, No. 7
Copyright © 1996, American Society for Microbiology

Transcription of a vaccinia virus late promoter template: requirement for the product of the A2L intermediate-stage gene

AL Passarelli, GR Kovacs and B Moss
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA.

Evidence is presented that a 26-kDa protein encoded by the vaccinia virus A2L open reading frame, originally shown to be one of three intermediate-stage genes that together can transactivate late-stage gene expression in transfection assays (J. G. Keck, C. J. Baldick, and B. Moss, Cell 61:801-809, 1990), is required for in vitro transcription of a template with a late promoter. The critical step in this analysis was the preparation of an extract containing all the required factors except for the A2L protein. This extract was prepared from cells infected with a recombinant vaccinia virus expressing the bacteriophage T7 RNA polymerase in the presence of the DNA synthesis inhibitor cytosine arabinoside and transfected with plasmids containing the two other known transactivator genes, A1L and G8R, under T7 promoter control. Reaction mixtures made with extracts of these cells had background levels of late transcription activity, unless they were supplemented with extracts of cells transfected with the A2L gene. Active transcription mixtures were also made by mixing extracts from three sets of cells, each transfected with a gene (A1L, A2L, or G8R) encoding a separate factor, indicating the absence of any requirement for their coexpression. To minimize the possibility that the A2L protein functions indirectly by activating another viral or cellular protein, this gene was expressed in insect cells by using a baculovirus vector. The partially purified recombinant protein complemented the activity of A2L-deficient cell extracts. Recombinant A1L, A2L, and G8R proteins, all produced in insect cells, together complemented extracts from mammalian cells containing only viral early proteins, concordant with previous in vivo transfection data.

This article has been cited by other articles:

• Katsafanas, G. C., Moss, B. (2004). Vaccinia Virus Intermediate Stage Transcription Is Complemented by Ras-GTPase-activating Protein SH3 Domain-binding Protein (G3BP) and Cytoplasmic Activation/Proliferation-associated Protein (p137) Individually or as a Heterodimer. J. Biol. Chem. 279: 52210-52217 [Abstract] [Full Text]  
• Shors, T., Keck, J. G., Moss, B. (1999). Down Regulation of Gene Expression by the Vaccinia Virus D10 Protein. J. Virol. 73: 791-796 [Abstract] [Full Text]  
• Gunasinghe, S. K., Hubbs, A. E., Wright, C. F. (1998). A Vaccinia Virus Late Transcription Factor with Biochemical and Molecular Identity to a Human Cellular Protein. J. Biol. Chem. 273: 27524-27530 [Abstract] [Full Text]  
• Zhu, M., Moore, T., Broyles, S. S. (1998). A Cellular Protein Binds Vaccinia Virus Late Promoters and Activates Transcription In Vitro. J. Virol. 72: 3893-3899 [Abstract] [Full Text]  
• Wright, C. F., Hubbs, A. E., Gunasinghe, S. K., Oswald, B. W. (1998). A Vaccinia Virus Late Transcription Factor Copurifies with a Factor That Binds to a Viral Late Promoter and Is Complemented by Extracts from Uninfected HeLa Cells. J. Virol. 72: 1446-1451 [Abstract] [Full Text]  
• Wright, C. F., Oswald, B. W., Dellis, S. (2001). Vaccinia Virus Late Transcription Is Activated in Vitro by Cellular Heterogeneous Nuclear Ribonucleoproteins. J. Biol. Chem. 276: 40680-40686 [Abstract] [Full Text]